tldrdailynews.com logo

Third Death Reported in China's Opaque CAR-T Trials

1 min read
Source: Endpoints News
Third Death Reported in China's Opaque CAR-T Trials
Photo: Endpoints News
TL;DR

A patient with an autoimmune disease died after receiving an experimental CAR-T gene therapy from a Chinese biotech startup, the third fatality in China’s controversial and opaque trials, according to Endpoints News.

Topics:businessscience#autoimmune-disease#car-t-therapy#china-biotech#clinical-trials#patient-safety#science
Share this article
  1. Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T  Endpoints News
  2. After 2 undisclosed deaths, can China’s IIT still be trusted?  Fierce Biotech
  3. After 2 Deaths and Reports of Brain Tumors, How Dangerous Is Gene Therapy, Really?  Gizmodo
  4. A fatal reaction  Stanford Law School
  5. Opinion | The Promise and Peril of Gene Editing  MedPage Today

Want the full story? Read the original reporting

Read on Endpoints News